Baxter International | BAX - Cost Of Sales


Baxter International reported $1.93B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 34.98M 3.04M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cooper Companies USD 401.3M 7.5M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Halozyme Therapeutics USD 108.68M 67K Jun/2026
ICU Medical USD 316.63M 7.37M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Laboratory Of America USD 2.7B 97.8M Jun/2026
Medtronic USD 3.83B 26M Jun/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Quest Diagnostics USD 2.05B 64M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026